Immuneering (IMRX) Common Stock Issued (2021 - 2026)
Immuneering (IMRX) reported Common Stock Issued of $220,174 for Q3 2026, down 48.2% from $424,663 a year earlier but up 794.7% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Common Stock Issued (2021 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Immuneering's Common Stock Issued came in at $655,374, up 16.9% year-over-year; for FY2025, it came in at $790,442, down 28.6% from FY2024.
- Common Stock Issued has a four-year compound annual growth rate of -71.6% (FY2021 to FY2025).
- By year, Common Stock Issued came in at $1.11 million in FY2024 (+148.9%), $444,838 in FY2023 (+48.1%), $300,379 in FY2022 (-99.8%) and $121.6 million in FY2021.
- Five-year quarterly Common Stock Issued spans a low of -$28.18 million in Q3 2023 and a high of $28.38 million in Q2 2023.
- Year over year, Common Stock Issued gained in two of the last four quarters, with growth averaging 33.6%.
- The high point for year-over-year Common Stock Issued in five years was Q4 2022 (growth of 459.9%); the low point was Q3 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $24,608 (Q2 2026), $180,760 (Q1 2026) and $229,832 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | 220,174.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 220,174.00 |
| Jun 30, 2026 | 24,608.00 |
| Mar 31, 2026 | 180,760.00 |
| Dec 31, 2025 | 229,832.00 |
| Sep 30, 2025 | 424,663.00 |
| Jun 30, 2025 | 2,055.00 |
| Mar 31, 2025 | 133,892.00 |
| Sep 30, 2024 | 127,187.00 |
| Mar 31, 2024 | 979,923.00 |
| Dec 31, 2023 | 7,835.00 |
| Sep 30, 2023 | -28.18 Mn |
| Jun 30, 2023 | 28.38 Mn |
| Mar 31, 2023 | 239,408.00 |
| Dec 31, 2022 | 42,098.00 |
| Sep 30, 2022 | 37,386.00 |
| Jun 30, 2022 | 27,784.00 |
| Mar 31, 2022 | 193,111.00 |
| Dec 31, 2021 | 7,519.00 |
| Sep 30, 2021 | 120.61 Mn |
API Access
Immuneering Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();